Importer and Distributor Obligations (EU)
MDR/IVDR places verification, labeling, traceability, and vigilance duties on importers and distributors.
Definition
Articles 13 and 14 of MDR (and parallel IVDR articles) require importers to verify CE marking, EC REP designation, labeling, and EUDAMED registration before placing a device on the EU market, and require distributors to maintain conditions of storage and transport and to react to non-conformities. Under MDR and IVDR Articles 13 and 14, importers must check that devices are CE marked, registered in EUDAMED, labeled correctly and have an authorised representative, and must put their own name and address on the device or packaging. Distributors must verify similar items by sampling. Both must keep complaint registers, cooperate on corrective actions and report suspected serious incidents to the manufacturer. Some relabeling or repackaging activities make them subject to Article 16.What this means in practice
These duties apply to every actor in the supply chain - not just the manufacturer - and are commonly cited in EU competent authority enforcement actions.Examples
- An importer verifies that a Class IIa surgical instrument bears a valid CE marking and that the manufacturer has appointed an EU authorized representative before making it available in an EU country.
- A distributor of in vitro diagnostic medical devices implements specific temperature control procedures for transport and storage to comply with the manufacturer's instructions and maintain device integrity.
- Upon receiving a complaint about a malfunctioning infusion pump, a distributor immediately notifies the manufacturer and isolates affected batches, documenting the entire process.
- •Importers often fail to conduct thorough checks of technical documentation before placing devices on the market, assuming the manufacturer has covered all aspects.
- •Distributors sometimes overlook the necessity of having a documented quality management system that addresses their specific obligations under the MDR.
- •A common mistake is not establishing clear communication channels and agreements with manufacturers regarding non-conformities and corrective actions.
- •Some economic operators wrongly assume that these obligations only apply to high-risk devices, rather than all devices covered by the MDR.
- •Failure to maintain accurate records of devices supplied and received can lead to significant compliance issues during audits.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsMore in Regulatory
· Same categoryFDA submission demonstrating a device is substantially equivalent to a legally marketed predicate.
Two alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.
Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification.
510(k) variant that relies on FDA guidance, special controls, or recognized consensus standards.
Where this term appears across MedTech Terms.
Latest in MedTech
Sources
3 sourcesEvery citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
- 1MDR Article 13/14Tier 1 VerifiedEUR-Lexeur-lex.europa.eu
- 2FDA - Medical DevicesTier 2 VerifiedFDAfda.gov
- 3European Commission - Medical DevicesTier 2 VerifiedEuropean Commissionhealth.ec.europa.eu
Inline markers like [1] jump to the matching reference above.